<<Would appreciate your clarification and facts on numbers 2 and 3 of your post.
1. A year with no product produced.
2. A constant need to sell stock to pay for day-to-day operations.
3. Trading BIO for IVY. (Definitely a trade down)>>
(2) The number of outstanding shares has increased to 118,000,000. They announced IVY was purchased with previously restricted shares. The only other thing EUTO could be selling the shares for is money for day-to-day operations.
<3> They had BIO which was a steady cash cow to help pay for day-to-day operations. But they sold it to "concentrate" on their core business: bringing companies public.
But they bought IVY to diversify and make money for day-to-day operations.
Basically, they traded BIO for IVY. Each serves the same purpose.
They seem to have a well-thought-out plan:
Sell company A for cash, claiming a desire to "concentrate on EUTO's core business.
Buy company B, using stock issued by the justification of bringing "value" to the EUTO.
Sell company B for cash, claiming a desire to "concentrate on EUTO's core business.
Buy company C, using stock issued by the justification of bringing "value" to the EUTO.
Sell company C for cash, claiming a desire to "concentrate on EUTO's core business.
Buy company D, using stock issued by the justification of bringing "value" to the EUTO.
Sell company D for cash, claiming a desire to "concentrate on EUTO's core business.
Buy company E, using stock issued by the justification of bringing "value" to the EUTO.
Lurker
(watching the shell game.)
|
